PTT-OV001
/ Pyrotech Therap
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 23, 2026
The clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of PTT-OV001 injection in the treatment of advanced solid tumors
(ChiCTR)
- P1 | N=51 | Not yet recruiting | Sponsor: Langfang Campus of Cancer Hospital, Chinese Academy of Medical Sciences; Langfang Campus of Cancer Hospital, Chinese Academy of Medical Sciences
New P1 trial • Cholangiocarcinoma • Hepatocellular Cancer • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1